✦ LIBER ✦

PCV52 ECONOMIC ANALYSIS OF THE USE OF CLOPIDOGREL IN PATIENTS WITH ACUTE CORONARY SYNDROME WITHOUT STSEGMENT ELEVATION (ACS) FROM THE RUSSIAN HEALTH CARE SYSTEM PERSPECTIVE

✍ Scribed by YB Belousov; LB Lazebnik; AV Bykov; T Nguyen; J Spiesser

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PCV45 Health Economic Evaluation of Tica

✍ L. Delgado-Ortega; J.L. López-Sendón; M. Heras Fortuny; C. Alvarez Sanz; E. Niko 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 58 KB

PCV101 IS PRASUGREL COST-EFFECTIVE RELAT

✍ A Davies; M Sculpher; C Schmitt; A Barrett; J Clouth; McCollam PL; A Bakhai 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 83 KB

PCV7 Cost-Effectiveness of Prasugrel Ver

✍ Mondragon, R.; Arrieta-Maturino, E.; Vargas-Valencia, J.J.; Martínez-Fonseca, J. 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 54 KB

PCV89 PRASUGREL COST-EFFECTIVE RELATIVE

✍ A Davies; M Sculpher; C Schmitt; A Barrett; J Baird; G Zanotti; A Bakhai 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 72 KB

PCV86 Long-Term Cost-Effectiveness Analy

✍ A. Garcia-Castillo; M. De-los-Rios; A.C. Polanco; M.A. Ramirez; E. Nikolic; C. M 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 72 KB

PCV26 Lifetime Cost-Effectiveness Analys

✍ Chin, C.T.; Mellström, C.; Chua, T.S.; Matchar, D.B. 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 67 KB